LIVDELZI is a prescription medicine used to treat PBC in combination with UDCA (also known as urso or ursodeoxycholic acid) in adults who have not responded well to UDCA, or used alone in patients unable to tolerate UDCA.
This once-daily pill is a game-changer for patients with primary biliary cholangitis (PBC), offering significant benefits such as reduced alkaline phosphatase (ALP) levels and relief from PBC- related itching—a common symptom affecting more than half of those with PBC.
LIVDELZI is now available as a prescription medication for treating PBC in adults. It can be used in combination with UDCA (ursodeoxycholic acid) for patients who haven’t responded well to UDCA alone or as a standalone treatment for those who cannot tolerate UDCA.
What is PBC?
PBC is a chronic condition that causes inflammation and damage to the small bile ducts in the liver, primarily impacting women aged 35 to 60. This new treatment brings hope and a vital new option for managing this disease.
Is Livdelzi right for you?
If you’re wondering whether Livdelzi is the right treatment for you, it’s important to talk to your healthcare provider. They can help you weigh your options based on your specific condition, medical history, and any other treatments you’re taking.